Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis.
The immunoglobulin-like transcript-4 (ILT4) is an inhibitory receptor that modulates the activity of innate immune agents. We determined the expression of ILT4 and analysed the relationship with the expression of costimulatory proteins and tumor necrosis factor-α (TNF-α) production in monocytes from...
Main Authors: | Alberto Bergamini, Maria Sole Chimenti, Eleonora Baffari, Maria Domenica Guarino, Gianfranco Gigliucci, Carlo Perricone, Roberto Perricone |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3967997?pdf=render |
Similar Items
-
Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib
by: Maria Sole Chimenti, et al.
Published: (2021-02-01) -
Profile of certolizumab and its potential in the treatment of psoriatic arthritis
by: Chimenti MS, et al.
Published: (2013-04-01) -
Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections
by: Carlo Perricone, et al.
Published: (2021-01-01) -
Evaluation of Clinical and Ultrasonographic Parameters in Psoriatic Arthritis Patients Treated with Adalimumab: A Retrospective Study
by: M. Teoli, et al.
Published: (2012-01-01) -
An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis
by: Chimenti MS, et al.
Published: (2020-08-01)